Go back

‘National biotechnology strategy needed’ in New Zealand

Panaramic view of famaus place at south island Queenstown in New Zealand

Genetic modification rules and limited access to capital are holding biotech R&D back, group says

BiotechNZ, a group representing companies and research bodies, has embarked on a campaign to increase investment in biotechnology research and change the rules around research into genetically modified materials.

A BiotechNZ report on the future of biotechnology in New Zealand says that access to capital and rules on genetic modification are the most significant constraints on local R&D. On 11 February in Dunedin, it held the first in a series of seminars aimed at boosting biotechnology in the country.

This article is only available to *Research Professional subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Alternatively, Pivot-RP users can log in and view the article via this link.